27773722|t|Prediction of pharmacokinetic and toxicological parameters of a 4-phenylcoumarin isolated from geopropolis: In silico and in vitro approaches
27773722|a|In silico and in vitro methodologies have been used as important tools in the drug discovery process, including from natural sources. The aim of this study was to predict pharmacokinetic and toxicity (ADME / Tox) properties of a coumarin isolated from geopropolis using in silico and in vitro approaches. Cinnamoyloxy-mammeisin (CNM) isolated from Brazilian M. scutellaris geopropolis was evaluated for its pharmacokinetic parameters by in silico models (ACD/Percepta™ and MetaDrug™ software). Genotoxicity was assessed by in vitro DNA damage signaling PCR array. CNM did not pass all parameters of Lipinski's rule of five, with a predicted low oral bioavailability and high plasma protein binding, but with good predicted blood brain barrier penetration. CNM was predicted to show low affinity to cytochrome P450 family members. Furthermore, the predicted Ames test indicated potential mutagenicity of CNM. Also, the probability of toxicity for organs and tissues was classified as moderate and high for liver and kidney, and moderate and low for skin and eye irritation, respectively. The PCR array analysis showed that CNM significantly upregulated about 7% of all DNA damage-related genes. By exploring the biological function of these genes, it was found that the predicted CNM genotoxicity is likely to be mediated by apoptosis. The predicted ADME / Tox profile suggests that external use of CNM may be preferable to systemic exposure, while its genotoxicity was characterized by the upregulation of apoptosis-related genes after treatment. The combined use of in silico and in vitro approaches to evaluate these parameters generated useful hypotheses to guide further preclinical studies.
27773722	0	10	Prediction	T078	C0681842
27773722	14	29	pharmacokinetic	T169	C0031328
27773722	34	58	toxicological parameters	T080	C0040539
27773722	64	80	4-phenylcoumarin	T109	C0299275
27773722	81	89	isolated	T169	C0205409
27773722	95	106	geopropolis	T121	C1254351
27773722	108	117	In silico	T066	C3489666
27773722	122	130	in vitro	T080	C1533691
27773722	142	151	In silico	T066	C3489666
27773722	156	164	in vitro	T080	C1533691
27773722	165	178	methodologies	T078	C3266812
27773722	220	234	drug discovery	T062	C0920472
27773722	259	274	natural sources	T033	C0243095
27773722	292	297	study	T062	C2603343
27773722	313	328	pharmacokinetic	T169	C0031328
27773722	333	341	toxicity	T080	C0040539
27773722	343	347	ADME	T062	C1510686
27773722	350	353	Tox	T080	C0040539
27773722	371	379	coumarin	T109,T121	C0010206
27773722	380	388	isolated	T169	C0205409
27773722	394	405	geopropolis	T121	C1254351
27773722	412	421	in silico	T066	C3489666
27773722	426	434	in vitro	T080	C1533691
27773722	447	469	Cinnamoyloxy-mammeisin	T121	C1254351
27773722	471	474	CNM	T121	C1254351
27773722	476	484	isolated	T169	C0205409
27773722	490	499	Brazilian	T083	C0006137
27773722	500	514	M. scutellaris	T204	C1499394
27773722	515	526	geopropolis	T121	C1254351
27773722	549	575	pharmacokinetic parameters	T169	C0031328
27773722	579	595	in silico models	T075	C0026336
27773722	597	610	ACD/Percepta™	T170	C0282574
27773722	615	633	MetaDrug™ software	T170	C0282574
27773722	636	648	Genotoxicity	T049	C0598309
27773722	665	673	in vitro	T080	C1533691
27773722	674	684	DNA damage	T049	C0012860
27773722	695	704	PCR array	T063	C3899376
27773722	706	709	CNM	T121	C1254351
27773722	727	737	parameters	T170	C0282574
27773722	741	764	Lipinski's rule of five	T170	C0282574
27773722	787	791	oral	T082	C0442027
27773722	792	807	bioavailability	T081	C0005508
27773722	817	839	plasma protein binding	T042	C0032119
27773722	865	896	blood brain barrier penetration	T042	C1254358
27773722	898	901	CNM	T121	C1254351
27773722	928	936	affinity	T070	C1510827
27773722	940	962	cytochrome P450 family	T116,T126	C0010762
27773722	999	1008	Ames test	T059,T063	C0598910
27773722	1029	1041	mutagenicity	T070	C1254365
27773722	1045	1048	CNM	T121	C1254351
27773722	1060	1071	probability	T081	C0033204
27773722	1075	1083	toxicity	T080	C0040539
27773722	1088	1094	organs	T023	C0178784
27773722	1099	1106	tissues	T024	C0040300
27773722	1147	1152	liver	T023	C0023884
27773722	1157	1163	kidney	T023	C0022646
27773722	1190	1194	skin	T033	C0152030
27773722	1199	1213	eye irritation	T033	C0235266
27773722	1233	1242	PCR array	T063	C3899376
27773722	1264	1267	CNM	T121	C1254351
27773722	1282	1293	upregulated	T044	C0041904
27773722	1310	1328	DNA damage-related	T049	C0012860
27773722	1329	1334	genes	T028	C0017337
27773722	1353	1372	biological function	T038	C3714634
27773722	1382	1387	genes	T028	C0017337
27773722	1421	1424	CNM	T121	C1254351
27773722	1425	1437	genotoxicity	T049	C0598309
27773722	1466	1475	apoptosis	T043	C0162638
27773722	1491	1495	ADME	T062	C1510686
27773722	1498	1501	Tox	T080	C0040539
27773722	1540	1543	CNM	T121	C1254351
27773722	1565	1573	systemic	T169	C0205373
27773722	1574	1582	exposure	T080	C0332157
27773722	1594	1606	genotoxicity	T049	C0598309
27773722	1632	1644	upregulation	T044	C0041904
27773722	1648	1665	apoptosis-related	T043	C0162638
27773722	1666	1671	genes	T028	C0017337
27773722	1678	1687	treatment	T061	C0087111
27773722	1709	1718	in silico	T066	C3489666
27773722	1723	1731	in vitro	T080	C1533691
27773722	1761	1771	parameters	T170	C0282574
27773722	1789	1799	hypotheses	T078	C1512571
27773722	1817	1836	preclinical studies	T062	C1709631